186 results
8-K
EX-10.2
TENX
Tenax Therapeutics, Inc.
6 Aug 24
Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement
7:23am
8-K
EX-10.1
TENX
Tenax Therapeutics, Inc.
6 Aug 24
Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement
7:23am
8-K
EX-10.2
TENX
Tenax Therapeutics, Inc.
13 Jun 24
Departure of Directors or Certain Officers
4:32pm
8-K
EX-10.1
TENX
Tenax Therapeutics, Inc.
13 Jun 24
Departure of Directors or Certain Officers
4:32pm
8-K
EX-10.1
TENX
Tenax Therapeutics, Inc.
20 Feb 24
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
8:33am
8-K
EX-10.2
5t14tp0817l
12 Feb 24
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
4:46pm
8-K
EX-10.1
nhf08t
12 Feb 24
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
4:46pm
8-K
EX-10.1
pl2amdu9gb0mdyo6fxz
10 Feb 23
Termination of a Material Definitive Agreement
4:31pm
8-K
EX-10.3
lbvelrw6xiwvvq4ppy
7 Feb 23
Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering
4:31pm
8-K
EX-10.1
1wq ztdhpkk8yslk
7 Feb 23
Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering
4:31pm
8-K
EX-10.2
te8laage41byugka0v
7 Feb 23
Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering
4:31pm
8-K
EX-10.1
v3g75sgrmts1h
16 Jun 22
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-10.2
jy3rk
10 Jun 22
Departure of Directors or Certain Officers
4:31pm
8-K
EX-10.1
1v4tv1uxjdm9
10 Jun 22
Departure of Directors or Certain Officers
4:31pm
8-K
EX-10.1
fjpe36 a4d0ddkdz0u
20 May 22
Tenax Therapeutics Announces Certain Securities and Nasdaq Disclosures
4:30pm
8-K
EX-10.2
vddusebanxfb429i
20 May 22
Tenax Therapeutics Announces Certain Securities and Nasdaq Disclosures
4:30pm